NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

I agree with that. I do, however, think they are not worried about the PPS or market value of NWBO in the short term. That will correct itself when NWBO gets the upfront payment for the partnership.

What I think a partnership will look like.

Upfront payment (very large amount. I have seen deals with $1-7B. I think we will be in the high end, which will take care of NWBO's valuation and SP)

Milestones:

Flaskworks approval (if they don't have it by the time DCVax-L gets approved)

Each approved use in other cancer indications

Each approved use in other forms of diseases

I think that unless there's significant equity stake taken by the partner, the future profit sharing from the sale of DCVax-L will be NWBO (50-70% and partner (30-50%)

Again, that is just my opinion, based on partnership deals I have seen in the past within pharmaceutical industry.